ARCHIVES

Long-Term Results Of STAR Find Raloxifene Causes Fewer, Less Severe Side Effects

This article is from The Cancer Letter archive.

Vol. 33 No. 4 | April 30, 2010

Download PDF Visit The Full Archive

Related Articles

ACS Urges Practice Of Insurance Exclusion End Under Reform

February 5, 1993

Clinical Trials Approved By NCI In November

December 28, 2001

Cooperative Groups, NCI To Talk About Overlaps

March 14, 1975

Kerrie Wilson Succeeds Alan Davis As ACS Chief Lobbyist

November 26, 1993

Clinical Trials Approved By NCI CTEP Last Month

January 28, 2011

Amgen Pays $24.9 Million To Settle Kickback Charges

April 19, 2013